Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

BACKGROUND: Induction chemotherapy (ICT) with docetaxel, cisplatin and fluorouracil (TPF) followed by radiotherapy is an effective treatment option for unresectable locally advanced head and neck cancer. This phase I study was designed to investigate the safety and tolerability of a split-dose TPF I...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Oertel, Katrin, Spiegel, Karin, Schmalenberg, Harald, Dietz, Andreas, Maschmeyer, Georg, Kuhnt, Thomas, Sudhoff, Holger, Wendt, Thomas G, Guntinas-Lichius, Orlando
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2012
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3485626/
https://ncbi.nlm.nih.gov/pubmed/23083061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-483
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة